Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hodgkins Disease”

3,585 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,585 results

Testing effectiveness (Phase 2)WithdrawnNCT00005969
What this trial is testing

Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00644124
What this trial is testing

Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Sanofi 25
Testing effectiveness (Phase 2)Ended earlyNCT00126243
What this trial is testing

Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma

Who this might be right for
AIDS Related Lymphoma
French National Agency for Research on AIDS and Viral Hepatitis 60
Testing effectiveness (Phase 2)Study completedNCT00048555
What this trial is testing

Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Biogen 90
Not applicableStudy completedNCT03595813
What this trial is testing

Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy

Who this might be right for
Lung Cancer MetastaticLocally Advanced Malignant NeoplasmNon Hodgkin Lymphoma+1 more
Institut Paoli-Calmettes 135
Post-approval studies (Phase 4)Study completedNCT00090038
What this trial is testing

Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Biogen 168
Early research (Phase 1)Study completedNCT00073749
What this trial is testing

Study Evaluating CMC-544 In B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, B-Cell
Pfizer 79
Early research (Phase 1)Study completedNCT01527838
What this trial is testing

Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Hodgkin's DiseaseChronic Lymphocytic Leukemia (CLL)+2 more
Fate Therapeutics 10
Large-scale testing (Phase 3)Looking for participantsNCT06170489
What this trial is testing

A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)

Who this might be right for
Hodgkin Lymphoma
Shanghai Junshi Bioscience Co., Ltd. 185
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Not applicableUnknownNCT04666168
What this trial is testing

Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed / Refractory Non Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin's Lymphoma
Hebei Senlang Biotechnology Inc., Ltd. 200
Testing effectiveness (Phase 2)Study completedNCT02213913
What this trial is testing

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Diffuse Large Cell Lymphoma+69 more
University of Chicago 55
Testing effectiveness (Phase 2)Looking for participantsNCT05907759
What this trial is testing

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Who this might be right for
Lymphoma, Primary Effusion
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT03436862
What this trial is testing

Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk

Who this might be right for
Hodgkin Lymphoma
SCRI Development Innovations, LLC 37
Early research (Phase 1)Active Not RecruitingNCT03479268
What this trial is testing

Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Prolymphocytic LeukemiaRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell Lymphoma+15 more
City of Hope Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT00003820
What this trial is testing

Rituximab in Treating Patients With Hodgkin's Lymphoma

Who this might be right for
LymphomaHodgkin Lymphoma (Category)Nodular Lymphocyte Predominant Hodgkin Lymphoma
Ranjana Advani 39
Early research (Phase 1)Study completedNCT00443976
What this trial is testing

Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkins LymphomaUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 35
Testing effectiveness (Phase 2)Study completedNCT01281917
What this trial is testing

Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
University of Wisconsin, Madison 40
Early research (Phase 1)Study completedNCT00005946
What this trial is testing

Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore
Not applicableStudy completedNCT01868451
What this trial is testing

Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 118
Load More Results